EVIDENCE LIBRARY
Irinotecan Twitching Case Used Lorazepam Before Later Infusions Rather Than During the Original Event
A case report described no recurrence after lorazepam premedication. That prophylactic observation should not be rewritten as immediate reversal of the first episode.
A case report described no recurrence after lorazepam premedication. That prophylactic observation should not be rewritten as immediate reversal of the first episode.
The timing
A patient developed pectoral muscle twitching during a chemotherapy infusion. The infusion was halted, and twitching slowly subsided over about four hours.
Before the next infusion, lorazepam was given in an attempt to prevent recurrence. The patient did not report further twitching, and premedication continued during subsequent cycles.
What the case can establish
The original episode improved before the later prophylactic regimen. The report therefore does not test lorazepam as rescue treatment for that initial event.
Absence of recurrence in one patient can reflect treatment, variability, changed exposure, or other factors. It cannot establish an optimal premedication dose, incidence of the reaction, or a general treatment standard. The case is useful for showing why drug administration and symptom timing must be preserved when distinguishing prevention, symptomatic relief, and spontaneous resolution.
Source paper
Original analysis of the supplied journal article, identified as PMC9905207.